STU 3 Ballot

This page is part of the FHIR Specification (v1.6.0: STU 3 Ballot 4). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R4 R3 R2

V3-VaccineManufacturer.xml

Raw XML (canonical form)

The manufacturer of a vaccine.

<ValueSet xmlns="http://hl7.org/fhir">
  <id value="v3-VaccineManufacturer"/>
  <meta>
    <lastUpdated value="2016-03-23T00:00:00.000+11:00"/>
    <profile value="http://hl7.org/fhir/StructureDefinition/valueset-shareable-definition"/>
  </meta>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml">
      <p>Release Date: 2016-03-23</p>

      <table class="grid">
 
        <tr>
          <td>
            <b>Level</b>
          </td>
          <td>
            <b>Code</b>
          </td>
          <td>
            <b>Display</b>
          </td>
          <td>
            <b>Definition</b>
          </td>
        </tr>
 
        <tr>
          <td>1</td>
          <td>AB
            <a name="AB"> </a>
          </td>
          <td>Abbott Laboratories (includes Ross Products Division)</td>
          <td>
                        Abbott Laboratories (includes Ross Products Division)
            <br/>

                     
          </td>
        </tr>
 
        <tr>
          <td>1</td>
          <td>AD
            <a name="AD"> </a>
          </td>
          <td>Adams Laboratories</td>
          <td>
                        Adams Laboratories
            <br/>

                     
          </td>
        </tr>
 
        <tr>
          <td>1</td>
          <td>ALP
            <a name="ALP"> </a>
          </td>
          <td>Alpha Therapeutic Corporation</td>
          <td>
                        Alpha Therapeutic Corporation
            <br/>

                     
          </td>
        </tr>
 
        <tr>
          <td>1</td>
          <td>AR
            <a name="AR"> </a>
          </td>
          <td>Armour [Inactive - use CEN]</td>
          <td>
                        Armour [Inactive-use CEN]
            <br/>

                     
          </td>
        </tr>
 
        <tr>
          <td>1</td>
          <td>AVI
            <a name="AVI"> </a>
          </td>
          <td>Aviron</td>
          <td>
                        Aviron
            <br/>

                     
          </td>
        </tr>
 
        <tr>
          <td>1</td>
          <td>BA
            <a name="BA"> </a>
          </td>
          <td>Baxter Healthcare Corporation</td>
          <td>
                        Baxter Healthcare Corporation
            <br/>

                     
          </td>
        </tr>
 
        <tr>
          <td>1</td>
          <td>BAY
            <a name="BAY"> </a>
          </td>
          <td>Bayer Corporation (includes Miles, Inc. and Cutter Laboratories)</td>
          <td>
                        Bayer Corporation (includes Miles, Inc. and Cutter Laboratories)
            <br/>

                     
          </td>
        </tr>
 
        <tr>
          <td>1</td>
          <td>BP
            <a name="BP"> </a>
          </td>
          <td>Berna Products [Inactive - use BPC]</td>
          <td>
                        Berna Products [Inactive-use BPC]
            <br/>

                     
          </td>
        </tr>
 
        <tr>
          <td>1</td>
          <td>BPC
            <a name="BPC"> </a>
          </td>
          <td>Berna Products Corporation (includes Swiss Serum and Vaccine Institute Berne)</td>
          <td>
                        Berna Products Corporation (includes Swiss Serum and Vaccine Institute
               Berne)
            <br/>

                     
          </td>
        </tr>
 
        <tr>
          <td>1</td>
          <td>CEN
            <a name="CEN"> </a>
          </td>
          <td>Centeon L.L.C. (includes Armour Pharmaceutical Company)</td>
          <td>
                        Centeon L.L.C. (includes Armour Pharmaceutical Company)
            <br/>

                     
          </td>
        </tr>
 
        <tr>
          <td>1</td>
          <td>CHI
            <a name="CHI"> </a>
          </td>
          <td>Chiron Corporation</td>
          <td>
                        Chiron Corporation
            <br/>

                     
          </td>
        </tr>
 
        <tr>
          <td>1</td>
          <td>CON
            <a name="CON"> </a>
          </td>
          <td>Connaught [Inactive - use PMC]</td>
          <td>
                        Connaught [Inactive-use PMC]
            <br/>

                     
          </td>
        </tr>
 
        <tr>
          <td>1</td>
          <td>EVN
            <a name="EVN"> </a>
          </td>
          <td>Evans Medical Limited (an affiliate of Medeva Pharmaceuticals, Inc.)</td>
          <td>
                        Evans Medical Limited (an affiliate of Medeva Pharmaceuticals,
               Inc.)
            <br/>

                     
          </td>
        </tr>
 
        <tr>
          <td>1</td>
          <td>GRE
            <a name="GRE"> </a>
          </td>
          <td>Greer Laboratories, Inc.</td>
          <td>
                        Greer Laboratories, Inc.
            <br/>

                     
          </td>
        </tr>
 
        <tr>
          <td>1</td>
          <td>IAG
            <a name="IAG"> </a>
          </td>
          <td>Immuno International AG</td>
          <td>
                        Immuno International AG
            <br/>

                     
          </td>
        </tr>
 
        <tr>
          <td>1</td>
          <td>IM
            <a name="IM"> </a>
          </td>
          <td>Merieux [Inactive - use PMC]</td>
          <td>
                        Merieux [Inactive-use PMC]
            <br/>

                     
          </td>
        </tr>
 
        <tr>
          <td>1</td>
          <td>IUS
            <a name="IUS"> </a>
          </td>
          <td>Immuno-U.S., Inc.</td>
          <td>
                        Immuno-U.S., Inc.
            <br/>

                     
          </td>
        </tr>
 
        <tr>
          <td>1</td>
          <td>JPN
            <a name="JPN"> </a>
          </td>
          <td>The Research Foundation for Microbial Diseases of Osaka University (BIKEN)</td>
          <td>
                        The Research Foundation for Microbial Diseases of Osaka University
               (BIKEN)
            <br/>

                     
          </td>
        </tr>
 
        <tr>
          <td>1</td>
          <td>KGC
            <a name="KGC"> </a>
          </td>
          <td>Korea Green Cross Corporation</td>
          <td>
                        Korea Green Cross Corporation
            <br/>

                     
          </td>
        </tr>
 
        <tr>
          <td>1</td>
          <td>LED
            <a name="LED"> </a>
          </td>
          <td>Lederle [Inactive - use WAL]</td>
          <td>
                        Lederle [Inactive-use WAL]
            <br/>

                     
          </td>
        </tr>
 
        <tr>
          <td>1</td>
          <td>MA
            <a name="MA"> </a>
          </td>
          <td>Massachusetts Public Health Biologic Laboratories</td>
          <td>
                        Massachusetts Public Health Biologic Laboratories
            <br/>

                     
          </td>
        </tr>
 
        <tr>
          <td>1</td>
          <td>MED
            <a name="MED"> </a>
          </td>
          <td>MedImmune, Inc.</td>
          <td>
                        MedImmune, Inc.
            <br/>

                     
          </td>
        </tr>
 
        <tr>
          <td>1</td>
          <td>MIL
            <a name="MIL"> </a>
          </td>
          <td>Miles [Inactive - use BAY]</td>
          <td>
                        Miles [Inactive-use BAY]
            <br/>

                     
          </td>
        </tr>
 
        <tr>
          <td>1</td>
          <td>MIP
            <a name="MIP"> </a>
          </td>
          <td>Bioport Corporation (formerly Michigan Biologic Products Institute)</td>
          <td>
                        Bioport Corporation (formerly Michigan Biologic Products Institute)
            <br/>

                     
          </td>
        </tr>
 
        <tr>
          <td>1</td>
          <td>MSD
            <a name="MSD"> </a>
          </td>
          <td>Merck and Co., Inc.</td>
          <td>
                        Merck &amp; Co., Inc.
            <br/>

                     
          </td>
        </tr>
 
        <tr>
          <td>1</td>
          <td>NAB
            <a name="NAB"> </a>
          </td>
          <td>NABI (formerly North American Biologicals, Inc.)</td>
          <td>
                        NABI (formerly North American Biologicals, Inc.)
            <br/>

                     
          </td>
        </tr>
 
        <tr>
          <td>1</td>
          <td>NAV
            <a name="NAV"> </a>
          </td>
          <td>North American Vaccine, Inc.</td>
          <td>
                        North American Vaccine, Inc.
            <br/>

                     
          </td>
        </tr>
 
        <tr>
          <td>1</td>
          <td>NOV
            <a name="NOV"> </a>
          </td>
          <td>Novartis Pharmaceutical Corporation (includes Ciba-Geigy Limited and Sandoz Limited)</td>
          <td>
                        Novartis Pharmaceutical Corporation (includes Ciba-Geigy Limited
               and Sandoz Limited)
            <br/>

                     
          </td>
        </tr>
 
        <tr>
          <td>1</td>
          <td>NYB
            <a name="NYB"> </a>
          </td>
          <td>New York Blood Center</td>
          <td>
                        New York Blood Center
            <br/>

                     
          </td>
        </tr>
 
        <tr>
          <td>1</td>
          <td>ORT
            <a name="ORT"> </a>
          </td>
          <td>Ortho Diagnostic Systems, Inc.</td>
          <td>
                        Ortho Diagnostic Systems, Inc.
            <br/>

                     
          </td>
        </tr>
 
        <tr>
          <td>1</td>
          <td>OTC
            <a name="OTC"> </a>
          </td>
          <td>Organon Teknika Corporation</td>
          <td>
                        Organon Teknika Corporation
            <br/>

                     
          </td>
        </tr>
 
        <tr>
          <td>1</td>
          <td>PD
            <a name="PD"> </a>
          </td>
          <td>Parkedale Pharmaceuticals (formerly Parke-Davis)</td>
          <td>
                        Parkedale Pharmaceuticals (formerly Parke-Davis)
            <br/>

                     
          </td>
        </tr>
 
        <tr>
          <td>1</td>
          <td>PMC
            <a name="PMC"> </a>
          </td>
          <td>Aventis Pasteur Inc. (formerly Pasteur Merieux Connaught; includes Connaught Laboratories
               and Pasteur Merieux)</td>
          <td>
                        Aventis Pasteur Inc. (formerly Pasteur Merieux Connaught; includes
               Connaught Laboratories and Pasteur Merieux)
            <br/>

                     
          </td>
        </tr>
 
        <tr>
          <td>1</td>
          <td>PRX
            <a name="PRX"> </a>
          </td>
          <td>Praxis Biologics [Inactive - use WAL]</td>
          <td>
                        Praxis Biologics [Inactive-use WAL]
            <br/>

                     
          </td>
        </tr>
 
        <tr>
          <td>1</td>
          <td>SCL
            <a name="SCL"> </a>
          </td>
          <td>Sclavo, Inc.</td>
          <td>
                        Sclavo, Inc.
            <br/>

                     
          </td>
        </tr>
 
        <tr>
          <td>1</td>
          <td>SI
            <a name="SI"> </a>
          </td>
          <td>Swiss Serum and Vaccine Inst. [Inactive - use BPC]</td>
          <td>
                        Swiss Serum and Vaccine Inst. [Inactive-use BPC]
            <br/>

                     
          </td>
        </tr>
 
        <tr>
          <td>1</td>
          <td>SKB
            <a name="SKB"> </a>
          </td>
          <td>SmithKline Beecham</td>
          <td>
                        SmithKline Beecham
            <br/>

                     
          </td>
        </tr>
 
        <tr>
          <td>1</td>
          <td>USA
            <a name="USA"> </a>
          </td>
          <td>United States Army Medical Research and Materiel Command</td>
          <td>
                        United States Army Medical Research and Materiel Command
            <br/>

                     
          </td>
        </tr>
 
        <tr>
          <td>1</td>
          <td>WA
            <a name="WA"> </a>
          </td>
          <td>Wyeth-Ayerst [Inactive - use WAL]</td>
          <td>
                        Wyeth-Ayerst [Inactive-use WAL]
            <br/>

                     
          </td>
        </tr>
 
        <tr>
          <td>1</td>
          <td>WAL
            <a name="WAL"> </a>
          </td>
          <td>Wyeth-Ayerst (includes Wyeth-Lederle Vaccines and Pediatrics, Wyeth Laboratories, Lederle
               Laboratories, and Praxis Biologics)</td>
          <td>
                        Wyeth-Ayerst (includes Wyeth-Lederle Vaccines and Pediatrics,
               Wyeth Laboratories, Lederle Laboratories, and Praxis Biologics)
            <br/>

                     
          </td>
        </tr>

      </table>

    </div>
  </text>
  <url value="http://hl7.org/fhir/ValueSet/v3-VaccineManufacturer"/>
  <identifier>
    <system value="urn:ietf:rfc:3986"/>
    <value value="urn:oid:2.16.840.1.113883.1.11.227"/>
  </identifier>
  <version value="2016-03-23"/>
  <name value="v3 Code System VaccineManufacturer"/>
  <status value="active"/>
  <experimental value="false"/>
  <publisher value="HL7, Inc"/>
  <contact>
    <telecom>
      <system value="other"/>
      <value value="http://hl7.org"/>
    </telecom>
  </contact>
  <date value="2016-03-23"/>
  <description value=" The manufacturer of a vaccine."/>
  <compose>
    <include>
      <system value="http://hl7.org/fhir/v3/VaccineManufacturer"/>
    </include>
  </compose>
</ValueSet>

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.